Argentine woman's affordable chemo cap offers hope by preventing hair
loss
Send a link to a friend
[August 30, 2022]
By Lucila Sigal
BUENOS AIRES (Reuters) - After doctors
diagnosed Paula Estrada with breast cancer in 2009, the then 41-year-old
Argentine decided she would not only beat the disease, but would do so
without losing her long blonde hair to the ravages of chemotherapy.
At her home in Buenos Aires, Estrada, a graphic designer by profession,
set about creating a makeshift cooling cap out of ice packs to keep her
scalp cold - and ward off hair loss.
It worked, and "nobody realized that I was undergoing chemotherapy,"
said Estrada, now 54.
Scalp cooling, a way to constrict blood vessels and keep chemotherapy
drugs from reaching hair follicles, has existed in some form for
decades. The Paxman Scalp Cooling cap, for example, was introduced in
Britain in 1997 and earned U.S. FDA approval in 2017.
But in 2009, cooling caps were an unknown in Argentina, Estrada said.
"When I finished, I said 'I'm not going to keep this for myself, I want
everyone to have this as a possibility," she recalled.
Estrada's 'Quimo con pelo' cap can be made with gels that cost as little
as $2 - a lifesaver in a country facing economic struggles and where
alternative cooling caps can cost $100 a session.
[to top of second column]
|
Former cancer patient Paula Estrada, who
created a cold helmet that prevents hair loss during chemotherapy,
shows here hair during an interview with Reuters, in Buenos Aires,
Argentina June 23, 2022. REUTERS/Matias Baglietto
On social media, patients in
Argentina and around the world share instructions on how to make the
caps and donate them when they're finished.
The caps must be used beginning with the first chemo session, kept
at -4 degrees Fahrenheit (-20 degrees Celsius), and changed every 30
minutes.
"It's worth it," said Mariangeles Fernandez, a 48-year-old liver
cancer patient. "It lets you fight the disease in a different way."
Estrada, who is now writing a book about her experience, says she
hears from patients every day whose cancer journeys have been
improved by the caps.
"I think the (cap) has been the key to my state of mind," said Elsa
Ram, a 64-year-old retiree with breast cancer. "This is a big part
of a good treatment."
(Reporting by Lucila Sigal, Writing by Carolina Pulice and Brendan
O'Boyle, Editing by Rosalba O'Brien)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|